全球霍亂疫苗市場規模、佔有率、成長分析（按最終用戶、類型）- 產業預測，2024-2031 年

Global Cholera Vaccines Market Size, Share, Growth Analysis, By End user(Hospitals, specialty clinics), By Type(Dukoral, Shanchol) - Industry Forecast 2024-2031

出版日期: 2024年03月09日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球霍亂疫苗市場規模為736.9億美元，在預測期內（2024-2031年）從2023年的790.7億美元成長到2031年的1389.3億美元，預計複合年成長率為7.3% 。

引起霍亂並損害腸道的細菌感染是透過受污染的食品和水傳播的。口腔、咽喉、鼻腔、眼瞼的肌肉痙攣和黏膜乾燥，以及嚴重腹瀉、發燒、脫水、腹痛、心率加快、皮膚彈性下降、血壓低、心率。全球公共衛生目前受到這種感染疾病的威脅，可以透過疫苗接種來阻止這種疾病。疫苗透過將身體暴露於微量的活霍亂細菌來幫助身體增強免疫力。疫苗可以口服、靜脈或肌肉內施用。疫苗是生物製藥提供對某些感染疾病的免疫力並幫助發展免疫系統。包括世界衛生組織（WHO）在內的許多國際組織都使用疫苗來治療感染疾病。霍亂是一種高度傳染性疾病，由飲用被霍亂弧菌污染的飲用水或飲水所引起。潛伏期短，數小時至5天不等，特徵是大量水樣腹瀉。霍亂有時可能致命。該疾病與衛生條件差、消毒不充分和缺乏清潔飲用水密切相關。該疾病可能呈流行病或地方病趨勢。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Sanofi SA
GlaxoSmithKline plc
PaxVax Inc.（現為 Emergent BioSolutions 的一部分）
Bharat Biotech
Valneva SE
EuBiologics Co. Ltd.
Shantha Biotechnics Private Limited（賽諾菲巴斯德旗下）
Bio Farma（Indonesia Vaccine Institute）
Eubiologics Co. Ltd.
Merck & Co., Inc.
Cipla Limited
Astellas Pharma Inc.
Takeda Pharmaceutical Company Limited
Panacea Biotec Ltd.
Serum Institute of India Pvt. Ltd.
Beijing Minhai Biotechnology Co. Ltd.
Biken Corporation
OCV 聯盟（比爾、梅琳達蓋茲基金會、世界衛生組織等）
PaxVax Bermuda Ltd.
GSK Biologicals SA.

簡介目錄

Product Code: SQMIG35I2103

Global Cholera Vaccines Market size was valued at USD 73.69 billion in 2022 and is poised to grow from USD 79.07 billion in 2023 to USD 138.93 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2024-2031).

The bacterial infections that cause cholera and damage the intestines are spread by contaminated food and water. Apart from cramping in the muscles and dryness of mucous membranes on the inside of the mouth, throat, nose, and eyelids, it also results in severe diarrhea, fever, dehydration, pain in the abdomen, rapid heartbeat, elasticity loss in the skin, low blood pressure, and fast heartbeat. Global public health is currently threatened by it, but immunization can halt it. By exposing the body to a tiny amount of live cholera bacteria, the vaccine helps the body acquire immunity. It can be taken orally, intravenously, or intramuscularly. A vaccination is a biological preparation that provides immunity to certain infectious diseases and aids in the development of the immune system. Vaccines are used to treat infectious diseases by a number of international organizations, including the World Health Organization (WHO). Cholera is a highly contagious disease that is caused by eating or drinking water contaminated with the vibrio cholera bacteria. The infection has a short incubation period of a few hours to five days and is characterized by abundant watery diarrhea. Cholera can occasionally prove fatal. The illness is closely linked to poor hygiene, insufficient sanitization, and a scarcity of clean drinking water. It can follow either an epidemic or an endemic trend.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholera Vaccines Market Segmental Analysis

The product type, administration method, end users, distribution channel, and geographic regions are the factors that divide the worldwide market for cholera vaccines. The cholera vaccines market is divided into three categories based on type: shanchol, euvichol, and dukoral. The market is split into oral and other categories based on the method of administration. The market is divided into end-user segments based on the following: hospitals, research & academic labs, pharmaceutical & biotechnology companies, specialty clinics, and others. The cholera vaccines market has also been divided into hospital pharmacies, retail pharmacies, and other segments based on the distribution channel.

Drivers of the Global Cholera Vaccines Market

The factors predicted to drive the growth of the cholera vaccines market are the creation of novel vaccine delivery systems, raised public knowledge of cholera preventative care, and the adoption of unhealthy lifestyle practices such inadequate sanitation and the consumption of tainted food. Furthermore, the government's increased emphasis on immunization campaigns has propelled the cholera vaccine market's growth. However, the FDA's more stringent standards and drawn-out clearance procedure for novel medications could pose a challenge to the global market for cholera vaccines.

Restraints in the Global Cholera Vaccines Market

Vaccines take a long time to produce, and the need for strict regulatory approvals is projected to impede market expansion over the projection period.

Market Trends of the Global Cholera Vaccines Market

The rising incidence of cholera in the general population is the main factor driving the global market. This is a result of the inadequate hygienic and sanitation conditions in rural and isolated locations. In addition, increased public knowledge of the existence of cholera vaccinations has increased demand for the product.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Cholera Vaccines Market by End user

Market Overview
Hospitals
specialty clinics
research and academic laboratories and pharmaceutical and biotechnology companies and others

Global Cholera Vaccines Market by Type

Market Overview
Dukoral
Shanchol
Vaxchora
Euvichol
and others

Global Cholera Vaccines Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PaxVax Inc. (now part of Emergent BioSolutions)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bharat Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Valneva SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EuBiologics Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shantha Biotechnics Private Limited (part of Sanofi Pasteur)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Farma (Indonesia Vaccine Institute)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eubiologics Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Biotec Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serum Institute of India Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing Minhai Biotechnology Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biken Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OCV Consortium (The Bill and Melinda Gates Foundation, WHO, and others)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PaxVax Bermuda Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK Biologicals SA.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments